Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Treponema pallidum

From Wikipedia, the free encyclopedia
Species of bacterium

Treponema pallidum
Scientific classificationEdit this classification
Domain:Bacteria
Kingdom:Pseudomonadati
Phylum:Spirochaetota
Class:Spirochaetia
Order:Spirochaetales
Family:Treponemataceae
Genus:Treponema
Species:
T. pallidum
Binomial name
Treponema pallidum
(Schaudinn &Hoffmann 1905) Schaudinn 1905
Synonyms[1]

"Spirochaeta pallida"Schaudinn & Hoffmann 1905[a]

Treponema pallidum, formerly known asSpirochaeta pallida,[a] is amicroaerophilic,gram-negative,spirochaetebacterium with subspecies that cause the diseasessyphilis,bejel (also known as endemic syphilis), andyaws.[2] It is known to be transmitted only among humans and baboons.[3]T. pallidum can enter the host through mucosal membranes or open lesions in the skin and is primarily spread through sexual contact.[2] It is a helically coiled microorganism usually 6–15 μm long and 0.1–0.2 μm wide.T. pallidum's lack of both atricarboxylic acid cycle and processes foroxidative phosphorylation results in minimal metabolic activity.[4] As achemoorganoheterotroph,Treponema pallidum is anobligate parasite that acquires its glucose carbon source from its host. Glucose can be used not only as a primary carbon source but also in glycolytic mechanisms to generate ATP needed to power the bacterium given its minimal genome.[5] The treponemes havecytoplasmic andouter membranes. Usinglight microscopy, treponemes are visible only by usingdark-field illumination.T. pallidum consists of three subspecies,T. p. pallidum, T. p. endemicum, andT. p. pertenue, each of which has a distinct related disorder. The ability ofT. pallidum to avoid host immune defenses has allowed for stealth pathogenicity.[2] The unique outer membrane structure and minimal expression of surface proteins ofT. pallidum has made vaccine development difficult.Treponema pallidum can be treated with high efficacy by antibiotics that inhibit bacterial cell wall synthesis such as the beta-lactam antimicrobialpenicillin-G.[6]

Subspecies

[edit]

Threesubspecies ofT. pallidum are known:[7]

  • Treponema pallidum pallidum, which causes syphilis
  • T. p. endemicum, which causes bejel or endemic syphilis
  • T. p. pertenue, which causes yaws

The three subspecies causingyaws,bejel, andsyphilis aremorphologically andserologically indistinguishable.[2] The genomes of three of theT. pertenue strains are similar to those of theT. pallidum strain, differing by only 0.2%, corresponding to virulence factors.[8] The three subspecies can be distinguished by genetics, using restriction fragment length polymorphism (RFLP), which utilizes techniques such asPCR,restriction digest andgel electrophoresis.[9] GenestprC,tprI, and the 5' flanking region oftpp15 can be used to differentiate between the three subspecies based on DNA fragment lengths and location of bands in gel electrophoresis.[10][11] These bacteria were originally classified as members of separate species, but DNA hybridization analysis indicates they are members of the same species.Treponema carateum, the cause ofpinta, remains a separate species because no isolate is available for DNA analysis.[12] Disease transmittance in subspeciesT. p. endemicum andT. p. pertenue is considered non-venereal.[13]T. p. pallidum is the most invasive pathogenic subspecies, whileT. carateum is the least invasive of the species.T. p. endemicum andT. p. pertenue are intermediately invasive.[13]

Laboratory identification

[edit]
Electron micrograph image ofT. pallidum cultured on epithelial cells of cotton-tail rabbits.

Treponema pallidum was first microscopically identified in syphilitic chancres byFritz Schaudinn andErich Hoffmann at theCharité in Berlin in 1905.[14] Historically, this bacterium was identified in the clinical laboratory through visualization in dark field microscopy.[15] This bacterium can be detected with special stains, such as theDieterle stain.T. pallidum is also detected byserology, includingnontreponemalVDRL,rapid plasma reagin, treponemal antibody tests (FTA-ABS),T. pallidum immobilization reaction, andsyphilis TPHA test.[16]

Microbiology

[edit]

Physiology

[edit]
Electron micrograph image ofT. pallidum, highlighted in gold.

Treponema pallidum is a helically shaped bacterium with highmotility consisting of an outer membrane,peptidoglycan layer,inner membrane,protoplasmic cylinder, andperiplasmic space.[13] It is often described asgram-negative, but its outer membrane lackslipopolysaccharide, which is found in the outer membrane of other gram-negative bacteria.[17] It has an endoflagellum (periplasmic flagellum) consisting of four mainpolypeptides, a core structure, and a sheath.[18] The flagellum is located within the periplasmic space and wraps around the protoplasmic cylinder. The flagellum is arranged in a helical shape.[19] The flagellar motor forT. pallidum lacks a P-ring, normally used for motility, and has a collar component instead, which is imbedded in the periplasm.[19] The peptidoglycan layer interacts with the endoflagellum which may aid in motility.[20]T. pallidum's outer membrane has the most contact with host cells and contains fewtransmembrane proteins, limitingantigenicity, while its cytoplasmic membrane is covered in lipoproteins.[21][19] The outer membrane adhesins ofT. pallidum, including fibronectin- and laminin-binding proteins, have the main function of attaching to host cells and cell-surface receptors, and they share antigenically related functional domains.[22] The genusTreponema has ribbons of cytoskeletal cytoplasmic filaments that run the length of the cell just underneath the cytoplasmic membrane.[23]

Outer membrane and surface antigens

[edit]

The ofT. pallidum has several features that have made it historically difficult to research. These include details such as its fragility.[24] The treponemal outer membrane (OM) proteins are key factors for the bacterium's pathogenesis, persistence, and immune evasion strategies.[24]Treponema's reputation as a "stealth pathogen" is primarily due to this unique (OM) structure, which serves to evade immune detection.[24]

The outer membrane ofTreponema pallidum contains a strikingly low concentration oftransmembrane proteins, approximately 100-fold lower than other gram-negative bacteria or otherspirochetes. This protects the cells fromantibodies attacking it, hence they exhibit a "puzzling lack of antigenicity".[25][4] The genome also revealed a bundle of 12 proteins and some putativehemolysins are potential virulence factors ofT. pallidum.[26] One protein, TprK, appears to constantly mutate to avoid immune response from its host.[27]

TP0126

[edit]

The TP0126 protein has been linked to the outer membrane protein family (OMP). This protein will sit in the outer membrane like aporin, which is supported bycircular dichroism recombinant TP0126, and will increase the virulence factor.[28] Researchers have classified the TP0126 protein in this class due to the homology between the protein and the porins of the OMPs.[29][28] This protein is encoded by the TP0126 gene, which is conserved over all strains ofT. pallidum.[29]

TP0326

[edit]

TP0326 is anortholog of the β-barrel assembly machineBam A. BamA apparatus inserts newly synthetized and exported outer membrane proteins into the outer membrane.[30]

TP0453

[edit]

TP0453 is a 287 amino acid protein associated with the inner membrane of the microbe's outer membrane.[31] This protein lacks the extensivebeta sheet structure that is characteristic of other membrane proteins, and does not traverse the outer membrane.[32] This protein's function has been hypothesized to be involved with control of nutrient uptake.[33]

TP0624

[edit]

Outer Membrane Protein A (OmpA) domain-containing proteins are necessary for maintaining structural integrity in gram-negative bacteria. These domains contain peptidoglycan binding sites which creates a "structural bridge between the peptidoglycan layer and the outer memebrane."[34] The protein TP0624 found inT.pallidum has been proposed to facilitate this structural link, as well as interactions between outer membrane proteins and corresponding domains on the thinpeptidoglycan layer.[34]

TP0751

[edit]

The TP0751 protein is a protein that is unique toT. pallidum, and it is thought to aid in attachment to the host's extra cellular membrane.[35] Since this protein aids in the attachment to the host, it sits on the surface of the cells, and in 2005, it was discovered that the TP0751 protein will attach to thelaminin component in the host'sextracellular matrix.[36] With that, it is thought that the TP0751 protein plays a key role in dissemination with the host.[36][35]

TP0965

[edit]

TP0965 is a protein that is critical for membrane fusion inT. pallidum, and is located in theperiplasm.[37] TP0965 causes endothelial barrier dysfunction, a hallmark of late-stage pathogenesis ofsyphilis.[38] It does this by reducing the expression of tight junction proteins, which in turn increases the expression of adhesion molecules and endothelial cell permeability, which eventually leads to disruption of theendothelial layer.[39]

Treponema repeat family of proteins

[edit]

TheTreponema repeat family of proteins (Tpr) are proteins expressed during the infection process. Tprs are formed by a conservedN-terminal domain, an amino-terminal stretch of about 50 amino acids, a central variable region, and a conservedC-terminal domain.[30] The many different types of Tpr include TprA, TprB, TprC, TprD, and TprE, but variability of TprK is the most relevant due to the immune escape characteristics it allows.[40]

Antigen variation in TprK is regulated by gene conversion. In this way, fragments of the seven variable regions (V1–V7), by nonreciprocal recombination, present in TprK and the 53 donor sites of TprD can be combined to produce new structured sequences.[41][42] TprK antigen variation can helpT. pallidum to evade a strong host immune reaction and can also allow the reinfection of individuals. This is possible because the newly structured proteins can avoid antibody-specific recognition. It is also suspected that the genes that encode for the TprK protein are essential inpathogenesis during the infection ofsyphilis.[43]

To introduce more phenotypic diversity,T. pallidum may undergophase variation. This process mainly happens in TprF, TprI, TprG, TprJ, and TprL, and it consists of a reversible expansion or contraction of polymeric repeats. These size variations can help the bacterium to quickly adapt to its microenvironment, dodge immune response, or even increase affinity to its host.[42]

Culture

[edit]

In the past century since its initial discovery, culturing the bacteria in vitro has been difficult.[44] Without the ability to grow and maintain the bacteria in a laboratory setting, discoveries regarding its metabolism andantimicrobial sensitivity were greatly impaired.[24] However, successful long-term cultivation ofT.pallidum in vitro was reported in 2017.[44] This was achieved using Sf1Ep epithelial cells from rabbits, which were a necessary condition for the continued multiplication and survival of the system.[45] The medium TpCM-2 was used, an alteration of more simple media which previously only yielded a few weeks of culture growth.[45] This success was the result of switching outminimal essential medium (MEM) with CMRL 1066, a complex tissue culture medium.[44] With development, new discoveries aboutT.pallidum's requirements for growth and gene expression may occur and in turn, yield research beneficial for the treatment and prevention of syphilis, outside of a host.[46] However, continuous efforts to growT. pallidum inaxenic culture have been unsuccessful, indicating that it does not satisfyKoch's postulates.[47] The challenge likely stems from the organism's strong adaptation to residing in mammalian tissue, resulting in a reduced genome and significant impairments in metabolic and biosynthetic functions.[45]

Optimal growth occurs at 33-35 °C, hence infection and lesion development occur on warmer skin areas, but not on colder ones such as the colder ear.[4]

Metabolism

[edit]

The bacteria rely on the enzyme glycerol-3-phosphate dehydrogenase (GPDH). GPDH is an alternative when managing electrons that are produced during metabolism. In the absence of the electron transport chain,T. pallidum uses GPDH to recycle the NAD+ by oxidizing glycerol-3-phosphate to dihydroxyacetone phosphate and make NAD+ to keep glycolysis and other redox-dependent energy reactions. By doing this, it helps balance the ATP yield without weighing down the protein's limited supply for essential tasks.[48]

T. pallidum uses an enzyme called pyrophosphate-dependent phosphofructokinase rather than ATP as a way to save energy and optimize its limited resources.[49]

T. pallidum manages without a complete tricarboxylic acid cycle and oxidative phosphorylation by using different efficient strategies including redox balancing and substrate-level to survive the nutrient-limited host environment.[2]

T. pallidum lacks enzyme orthologs forsuperoxide dismutase, however it does possess asuperoxide reductase, maintaining the ability to reducereactive oxygen species. In addition,T. pallidum encodes an alkyl hydroperoxide reductase C, which allows for the reduction ofhydrogen peroxide to water and alcohols. This enzyme relies on TP0919, a protein present in the cytoplasm ofT. pallidum.[50]

T.pallidum primarily relies on glucose as its primary carbon source through glycolysis,[51] but one study has proposed the bacterium uses an acetogenic-energy conservation pathway as a way to catabolize D-lactate as an alternative carbon source. Currently, three proteins from the pathway have been identified, of which includeD-lactate dehydrogenase,phosphotransacetylase, and theacetate kinase.[52][53] The acetate kinase specifically acts to catabolize D-lactate for substrate-level phosphorylation of ADP into ATP, producing acetate as a byproduct. This pathway, which takes place in the cytoplasm, can also generate ATP by assisting the maintenance of the electrochemical gradient that lies between the periplasm and cytoplasm ofT.pallidum.[54]

Genome

[edit]

The genome ofT. pallidum was first sequenced in 1998 and revealed a small 1.14 Mbp genome, one of the smallest bacterial genomes. The G + C content is 52.8%.[55] The DNA sequences ofT. pallidum species are more than 99.7% identical, and PCR-based assays are effective at differentiating these species.[56][57] About 92.9% of DNA was determined to beopen reading frames, 55% of which had predicted biological functions,[4] while 17% matched hypothetical proteins of unknown function in other organisms and the remainder (28%) did not have significant similarity to other known sequences.[4]

The small size of theT. pallidum genome indicates that the species has limited metabolic capabilities, and thus mostly relies on its host for many molecules typically provided by biosynthetic pathways. For instance, it is missing genes encoding key enzymes in oxidative phosphorylation and the tricarboxylic acid cycle.[58] Thus,T.pallidum is no longer able to synthesize fatty acids, nucleic acids, and amino acids, instead relying on its mammalian hosts for these materials.[46][59][60]T.pallidum's low levels of diversity within its DNA sequence, forces the pathogen to utilize horizontal gene transfer for genetic diversity, although the specific mechanism is not well understood. It may possibly be a clonal species that still employs recombination.[61]

The strainsT. pallidumpertenue (TPE) andT.pallidumendemicum (TEN) also experience gene transfer via different subspecies but are notably geographically isolated. Coinfection in humans of two separate subspecies strains may be possible, as indicated by a recombination event at theT.pallidium clade within their phylogenetic lineage.[61]

Clinical significance

[edit]

The clinical features of syphilis, yaws, and bejel occur in multiple stages that affect the skin. The skin lesions observed in the early stage last for weeks or months. The skin lesions are highly infectious, and the spirochetes in the lesions are transmitted by direct contact. The lesions regress as the immune response develops againstT. pallidum. The latent stage that results can last a lifetime in many cases. In a few cases, the disease exits latency and enters a tertiary phase, in which destructive lesions of skin, bone, and cartilage ensue. Unlike yaws and bejels, syphilis in its tertiary stage often affects the heart, eyes, and nervous system, as well.[12]

Syphilis

[edit]
Main article:Syphilis

Treponema pallidum pallidum is a motile spirochete that is generally acquired by closesexual contact, entering the host via breaches in squamous or columnarepithelium. The organism can also be transmitted to a fetus bytransplacental passage during the later stages of pregnancy, giving rise to congenital syphilis.[61] The helical structure ofT. p. pallidum allows it to move in a corkscrew motion through mucous membranes or enter minuscule breaks in the skin. In women, the initial lesion is usually on the labia, the walls of the vagina, or the cervix; in men, it is on the shaft or glans of the penis.[13] It gains access to the host's blood and lymph systems through tissue and mucous membranes. In more severe cases, it may gain access to the host by infecting the skeletal bones and central nervous system of the body.[13] Despite effective antibiotic treatment since the mid twentieth century, this infection has been emerging globally in the last few decades.[62] In 2021, approximately 6 million new infections occurred globally.[63] In laboratory cultures, some contemporary variants ofT. p. pallidum strains have been failing to respond to the second line antibiotic azithromycin. This phylogenetic divergence and global presence point to the emergence of a pandemic strain cluster.[62] In addition to phylogenetic divergence, the switch to confidential record keeping resulted in an overall decrease in quality of tracking and recording disease prevalence.[64]

The incubation period for aT. p. pallidum infection is usually around 21 days, but can range from 10 to 90 days.[65]

Due to its problematic cultivation in laboratory conditions, much is still unknown about the pathogenesis ofT.pallidum. In 2023, Hu YT et al. published an article about thein vitro interaction between microglia cells andT. pallidum, which could prove to be significant in case of neurosyphilis. They have confirmed underlying mechanism of how the bacteria induce microglial apoptosis and simultaneously inhibit its clearance. They have discovered that T. pallidum activates microglia and induces autophagy on one side, but on the other side it interferes with mTORC1/TFEB pathway. This pathway is an important pathway, where the inhibition of mTORC1 signalling causes the nuclear translocation of transcription factor EB (TFEB). TFEB is a master regulator of lysosome biogenesis and its translocation to the nucleus induces the transcription of lysosomal genes and the production of lysosomes.T. pallidum interferes in this pathway by activating mTORC1, which inhibits nuclear translocation of TFEB, which consequently inhibits lysosomal biogenesis and autophagic flux. That leads into accumulation of autophagosomes, which in turn leads to microglial apoptosis and prevents the clearance ofT. pallidum. This study offers good foundation for further studies ofT. pallidum pathogenesis and potentially new therapeutic targets.[66]

A map depicting the deaths per million persons caused by syphilis produced with data from the WHO (2012).

Yaws

[edit]
Main article:Yaws

The causative agent of yaws isTreponema pallidum pertenue, which is transmissible by direct physical contact between infected people.[67] Yaws is not sexually transmitted, and occurs in tropical, humid environments of Africa, Pacific Islands, Asia and South America.[68][69] Unlike syphilis, which displaysvertical transmission, one strain ofT. p. pertenue researched was not vertically transmissible in a guinea pig model, and yaws cannot be spread from mother to offspring.[70][68] Yaws appears as skin lesions, usuallypapules, commonly on the lower extremities, but present in other areas such as the arms, trunk and hands.[71] Three stages of yaws disease have been documented: primary yaws which presents as inflamed sores on the lower body, secondary yaws which presents as a variety of skin abnormalities along with bone inflammation, and tertiary yaws, also referred to as latent yaws, which occurs whenT. p. pertenue is serologically detected in the host but no clinical signs are displayed until relapse, which often occurs years later.[72][73] Yaws is treated with antibiotics such asazithromycin andbenzathine penicillin-G.[74]

Bejel

[edit]

Bejel is caused byTreponema pallidum endemicum and is a disease is that endemic in hot and dry climates. The transmission path has not been fully mapped, however infections are thought to be transmitted via direct contact with lesion secretions or fomites rather than by sexual transmission.[75] Bejel typically causes skin lesions, which first appear as small ulcers in the mouth, and secondary lesions that form in the oropharynx, or around the nipples of nursing women.[57] Bejel can be treated withbenzathine penicillin-G.[76]

Non-human infection

[edit]

Treponema pallidum has been found in non-human primates in multiple different geographical regions. In Tanzania specifically,T. pallidum geographical distribution closely aligns with the distribution of yaws in humans. The most common strains in NHPs areT. p. pertenue andT. p.endemicum. It is unclear however whether or not these NHP strains can naturally infect humans, but flies have been proposed as possible vectors in an alternative transmission route. Clinically, these infections range from asymptomatic to severe skin ulceration that affect the face or genitalia in these primates. Infection of NHPs is largely reliant on ecological patterns, behaviors, and interactions between the species.[77] There are no current treatments available for infected NHPs.[77]

Treatment

[edit]

During the early 1940s, rabbit models in combination with the drugpenicillin allowed for a long-term drug treatment. These experiments established the groundwork that modern scientists use for syphilis therapy. Penicillin can inhibitT. pallidum in 6–8 hours, though the cells still remain in lymph nodes and regenerate. Penicillin is not the only drug that can be used to inhibitT. pallidum; anyβ-lactam antibiotics ormacrolides can be used.[78] TheT. pallidum strain 14 has built-in resistance to some macrolides, includingerythromycin andazithromycin. Resistance to macrolides inT. pallidum strain 14 is believed to derive from a single-point mutation that increased the organism's livability.[79] Many of the syphilis treatment therapies only lead tobacteriostatic results, unless larger concentrations of penicillin are used forbactericidal effects.[78][79] Penicillin overall is the most recommended antibiotic by the Centers for Disease Control, as it shows the best results with prolonged use. It can inhibit and may even killT. pallidum at low to high doses, with each increase in concentration being more effective.[79] The Guideline Development Group has recommended the development of a new treatment, a short course treatment that is administered orally and can cross the placental barriers in pregnant women.[80]

Vaccine

[edit]

Novaccine for syphilis is currently available, but doxycycline postexposure prophylaxis can be used to prevent infections.[81][82] The outer membrane ofT. pallidum has too few surface proteins for anantibody to be effective.The outer membrane ofT.pallidum has very few confirmed surface-exposed proteins, which due to the organism's elaborate biology and slow growth, has hindered progress towards the development of an effective syphilis vaccine.[83][84][85] In contrast, some of the antigenic targets ofT.pallidum are located in the periplasmic space or inner membrane, rather than being fully surface-exposed, which limits antibodies' effectiveness when trying to clear the infection.[86] In the last century, several prototypes have been developed, and while none of them provided protection from the infection, some prevented bacteria from disseminating to distal organs and promoted accelerated healing.[87]

Notes

[edit]
  1. ^abThis name is not considered to be validly published by theList of Prokaryotic names with Standing in Nomenclature[1]

References

[edit]
  1. ^abspecies/treponema-pallidum entry inLPSN;Parte AC, Sardà Carbasse J, Meier-Kolthoff JP, Reimer LC, Göker M (1 November 2020)."List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ".International Journal of Systematic and Evolutionary Microbiology.70 (11):5607–5612.doi:10.1099/ijsem.0.004332.
  2. ^abcdeRadolf JD, Deka RK, Anand A, Šmajs D, Norgard MV, Yang XF (10 October 2016)."Treponema pallidum, the syphilis spirochete: making a living as a stealth pathogen".Nature Reviews. Microbiology.14 (12):744–759.doi:10.1038/nrmicro.2016.141.ISSN 1740-1534.PMC 5106329.PMID 27721440.
  3. ^"ClinicalKey".www.clinicalkey.com. Retrieved12 November 2024.
  4. ^abcdeNorris SJ, Cox DL, Weinstock GM (3 January 2001). "Biology of Treponema pallidum: correlation of functional activities with genome sequence data".Journal of Molecular Microbiology and Biotechnology.3 (1):37–62.ISSN 1464-1801.PMID 11200228.
  5. ^Brautigam CA, Deka RK, Liu WZ, Norgard MV (2016)."The Tp0684 (MglB-2) Lipoprotein of Treponema pallidum: A Glucose-Binding Protein with Divergent Topology".PLOS ONE.11 (8) e0161022.Bibcode:2016PLoSO..1161022B.doi:10.1371/journal.pone.0161022.ISSN 1932-6203.PMC 4990184.PMID 27536942.
  6. ^Gartlan WA, Rahman S, Pellegrini MV, Reti K (2024),"Benzathine Penicillin",StatPearls, Treasure Island (FL): StatPearls Publishing,PMID 29939545, retrieved12 November 2024
  7. ^Marks M, Solomon AW, Mabey DC (October 2014)."Endemic treponemal diseases".Transactions of the Royal Society of Tropical Medicine and Hygiene.108 (10):601–7.doi:10.1093/trstmh/tru128.PMC 4162659.PMID 25157125.
  8. ^Čejková D, Zobaníková M, Chen L, Pospíšilová P, Strouhal M, Qin X, Mikalová L, Norris SJ, Muzny DM, Gibbs RA, Fulton LL, Sodergren E, Weinstock GM, Šmajs D (24 January 2012)."Whole Genome Sequences of Three Treponema pallidum ssp. pertenue Strains: Yaws and Syphilis Treponemes Differ in Less than 0.2% of the Genome Sequence".PLOS Neglected Tropical Diseases.6 (1) e1471.doi:10.1371/journal.pntd.0001471.ISSN 1935-2735.PMC 3265458.PMID 22292095.
  9. ^Zondag HC, Bruisten SM, Vrbová E, Šmajs D (2020)."No bejel among Surinamese, Antillean and Dutch syphilis diagnosed patients in Amsterdam between 2006-2018 evidenced by multi-locus sequence typing of Treponema pallidum isolates".PLOS ONE.15 (3) e0230288.Bibcode:2020PLoSO..1530288Z.doi:10.1371/journal.pone.0230288.PMC 7065763.PMID 32160272.
  10. ^Centurion-Lara A, Molini BJ, Godornes C, Sun E, Hevner K, Van Voorhis WC, Lukehart SA (September 2006)."Molecular differentiation of Treponema pallidum subspecies".Journal of Clinical Microbiology.44 (9):3377–3380.doi:10.1128/JCM.00784-06.ISSN 0095-1137.PMC 1594706.PMID 16954278.
  11. ^Centurion-Lara A, Castro C, Castillo R, Shaffer JM, Van Voorhis WC, Lukehart SA (April 1998). "The flanking region sequences of the 15-kDa lipoprotein gene differentiate pathogenic treponemes".The Journal of Infectious Diseases.177 (4):1036–1040.doi:10.1086/515247.ISSN 0022-1899.PMID 9534979.
  12. ^abGiacani L, Lukehart SA (January 2014)."The endemic treponematoses".Clinical Microbiology Reviews.27 (1):89–115.doi:10.1128/CMR.00070-13.PMC 3910905.PMID 24396138.
  13. ^abcdeRadolf JD (1996). Baron S (ed.).Treponema (4th ed.). Galveston (TX): University of Texas Medical Branch at Galveston.ISBN 978-0-9631172-1-2.PMID 21413263. NBK7716. Retrieved13 February 2019.
  14. ^Stamm LV (2015)."Yaws: 110 Years After Castellani's Discovery of Treponema pallidum subspecies pertenue".The American Society of Tropical Medicine and Hygiene.93 (1):4–6.doi:10.4269/ajtmh.15-0147.PMC 4497901.PMID 25870417. Retrieved30 October 2025.
  15. ^Theel ES, Katz SS, Pillay A (24 June 2020)."Molecular and Direct Detection Tests for Treponema pallidum Subspecies pallidum: A Review of the Literature, 1964–2017".Clinical Infectious Diseases.71 (Supplement_1):S4 –S12.doi:10.1093/cid/ciaa176.ISSN 1058-4838.PMC 7312206.PMID 32578865.
  16. ^Fisher B, Harvey RP, Champe PC (2007).Lippincott's Illustrated Reviews: Microbiology. Lippincott's Illustrated Reviews Series. Hagerstown, MD: Lippincott Williams & Wilkins.ISBN 978-0-7817-8215-9.
  17. ^Peeling RW, Mabey D, Kamb ML, Chen XS, Radolf JD, Benzaken AS (October 2017)."Syphilis".Nature Reviews. Disease Primers.3 17073.doi:10.1038/nrdp.2017.73.PMC 5809176.PMID 29022569.
  18. ^San Martin F, Fule L, Iraola G, Buschiazzo A, Picardeau M (1 March 2023)."Diving into the complexity of the spirochetal endoflagellum".Trends in Microbiology.31 (3):294–307.doi:10.1016/j.tim.2022.09.010.ISSN 0966-842X.PMID 36244923.S2CID 252916923.
  19. ^abcLi C, Corum L, Morgan D, Rosey EL, Stanton TB, Charon NW (December 2000)."The Spirochete FlaA Periplasmic Flagellar Sheath Protein Impacts Flagellar Helicity".Journal of Bacteriology.182 (23):6698–6706.doi:10.1128/jb.182.23.6698-6706.2000.PMC 111413.PMID 11073915.
  20. ^Izard J, Renken C, Hsieh CE, Desrosiers DC, Dunham-Ems S, La Vake C, Gebhardt LL, Limberger RJ, Cox DL, Marko M, Radolf JD (15 December 2009)."Cryo-Electron Tomography Elucidates the Molecular Architecture of Treponema pallidum , the Syphilis Spirochete".Journal of Bacteriology.191 (24):7566–7580.doi:10.1128/JB.01031-09.ISSN 0021-9193.PMC 2786590.PMID 19820083.
  21. ^Norris SJ, Cox DL, Weinstock GM (2001)."Biology ofTreponema pallidum: Correlation of Functional Activities With Genome Sequence Data"(PDF).JMMB Review.3 (1):37–62.PMID 11200228.
  22. ^Cameron CE, Brown EL, Kuroiwa JM, Schnapp LM, Brouwer NL (October 2004)."Treponema pallidum fibronectin-binding proteins".Journal of Bacteriology.186 (20):7019–7022.doi:10.1128/JB.186.20.7019-7022.2004.ISSN 0021-9193.PMC 522185.PMID 15466055.
  23. ^Izard J (2006)."Cytoskeletal Cytoplasmic Filament Ribbon of Treponema: A Member of an Intermediate-Like Filament Protein Family".Microbial Physiology.11 (3–5):159–166.doi:10.1159/000094052.ISSN 2673-1665.PMID 16983193.
  24. ^abcdRadolf JD, Kumar S (2018). "TheTreponema pallidum Outer Membrane".Spirochete Biology: The Post Genomic Era. Current Topics in Microbiology and Immunology. Vol. 415. pp. 1–38.doi:10.1007/82_2017_44.ISBN 978-3-319-89637-3.ISSN 0070-217X.PMC 5924592.PMID 28849315.
  25. ^Willey 2020, p. 499
  26. ^Weinstock GM, Hardham JM, McLeod MP, Sodergren EJ, Norris SJ (1 October 1998)."The genome ofTreponema pallidum: new light on the agent of syphilis".FEMS Microbiology Reviews.22 (4):323–332.doi:10.1111/j.1574-6976.1998.tb00373.x.PMID 9862125.
  27. ^Pinto M, Borges V, Antelo M, Pinheiro M, Nunes A, Azevedo J, Borrego MJ, Mendonça J, Carpinteiro D, Vieira L, Gomes JP (17 October 2016)."Genome-scale analysis of the non-cultivable Treponema pallidum reveals extensive within-patient genetic variation".Nature Microbiology.2 (1): 16190.doi:10.1038/nmicrobiol.2016.190.ISSN 2058-5276.PMID 27748767.
  28. ^abGiacani L, Brandt SL, Ke W, Reid TB, Molini BJ, Iverson-Cabral S, Ciccarese G, Drago F, Lukehart SA, Centurion-Lara A (June 2015)."Transcription of TP0126, Treponema pallidum putative OmpW homolog, is regulated by the length of a homopolymeric guanosine repeat".Infection and Immunity.83 (6):2275–2289.doi:10.1128/IAI.00360-15.ISSN 1098-5522.PMC 4432754.PMID 25802057.
  29. ^abHaynes AM, Godornes C, Ke W, Giacani L (August 2019)."Evaluation of the Protective Ability of the Treponema pallidum subsp. pallidum Tp0126 OmpW Homolog in the Rabbit Model of Syphilis".Infection and Immunity.87 (8): e00323–19.doi:10.1128/IAI.00323-19.ISSN 1098-5522.PMC 6652746.PMID 31182617.
  30. ^abHawley KL, Montezuma-Rusca JM, Delgado KN, Singh N, Uversky VN, Caimano MJ, Radolf JD, Luthra A (8 July 2021). Galperin MY (ed.)."Structural Modeling of theTreponema pallidum Outer Membrane Protein Repertoire: a Road Map for Deconvolution of Syphilis Pathogenesis and Development of a Syphilis Vaccine".Journal of Bacteriology.203 (15): e0008221.doi:10.1128/JB.00082-21.PMC 8407342.PMID 33972353.
  31. ^Hazlett KR, Cox DL, Decaffmeyer M, Bennett MP, Desrosiers DC, La Vake CJ, La Vake ME, Bourell KW, Robinson EJ, Brasseur R, Radolf JD (15 September 2005)."TP0453, a Concealed Outer Membrane Protein of Treponema pallidum, Enhances Membrane Permeability".Journal of Bacteriology.187 (18):6499–6508.doi:10.1128/jb.187.18.6499-6508.2005.PMC 1236642.PMID 16159783.
  32. ^Hazlett KR, Cox DL, Decaffmeyer M, Bennett MP, Desrosiers DC, La Vake CJ, La Vake ME, Bourell KW, Robinson EJ, Brasseur R, Radolf JD (September 2005)."TP0453, a concealed outer membrane protein ofTreponema pallidum, enhances membrane permeability".Journal of Bacteriology.187 (18):6499–6508.doi:10.1128/JB.187.18.6499-6508.2005.PMC 1236642.PMID 16159783.
  33. ^Luthra A, Zhu G, Desrosiers DC, Eggers CH, Mulay V, Anand A, McArthur FA, Romano FB, Caimano MJ, Heuck AP, Malkowski MG, Radolf JD (2 December 2011)."The transition from closed to open conformation ofTreponema pallidum outer membrane-associated lipoprotein TP0453 involves membrane sensing and integration by two amphipathic helices".The Journal of Biological Chemistry.286 (48):41656–68.doi:10.1074/jbc.M111.305284.ISSN 1083-351X.PMC 3308875.PMID 21965687.
  34. ^abParker ML, Houston S, Wetherell C, Cameron CE, Boulanger MJ (10 November 2016)."The Structure ofTreponema pallidum Tp0624 Reveals a Modular Assembly of Divergently Functionalized and Previously Uncharacterized Domains".PLOS ONE.11 (11) e0166274.Bibcode:2016PLoSO..1166274P.doi:10.1371/journal.pone.0166274.PMC 5104382.PMID 27832149.
  35. ^abParker ML, Houston S, Pětrošová H, Lithgow KV, Hof R, Wetherell C, Kao WC, Lin YP, Moriarty TJ, Ebady R, Cameron CE, Boulanger MJ (September 2016)."The Structure of Treponema pallidum Tp0751 (Pallilysin) Reveals a Non-canonical Lipocalin Fold That Mediates Adhesion to Extracellular Matrix Components and Interactions with Host Cells".PLOS Pathogens.12 (9) e1005919.doi:10.1371/journal.ppat.1005919.ISSN 1553-7374.PMC 5040251.PMID 27683203.
  36. ^abCameron CE, Brouwer NL, Tisch LM, Kuroiwa JM (November 2005)."Defining the interaction of the Treponema pallidum adhesin Tp0751 with laminin".Infection and Immunity.73 (11):7485–7494.doi:10.1128/IAI.73.11.7485-7494.2005.ISSN 0019-9567.PMC 1273862.PMID 16239550.
  37. ^McKevitt M, Brinkman MB, McLoughlin M, Perez C, Howell JK, Weinstock GM, Norris SJ, Palzkill T (July 2005)."Genome Scale Identification of Treponema pallidum Antigens".Infection and Immunity.73 (7):4445–4450.doi:10.1128/iai.73.7.4445-4450.2005.PMC 1168556.PMID 15972547.
  38. ^McKevitt M, Brinkman MB, McLoughlin M, Perez C, Howell JK, Weinstock GM, Norris SJ, Palzkill T (July 2005)."Genome Scale Identification ofTreponema pallidum Antigens".Infection and Immunity.73 (7):4445–50.doi:10.1128/iai.73.7.4445-4450.2005.PMC 1168556.PMID 15972547.
  39. ^Zhang RL, Zhang JP, Wang QQ (16 December 2014)."RecombinantTreponema pallidum Protein Tp0965 Activates Endothelial Cells and Increases the Permeability of Endothelial Cell Monolayer".PLOS ONE.9 (12) e115134.Bibcode:2014PLoSO...9k5134Z.doi:10.1371/journal.pone.0115134.PMC 4267829.PMID 25514584.
  40. ^Hazlett KR, Sellati TJ, Nguyen TT, Cox DL, Clawson ML, Caimano MJ, Radolf JD (30 April 2001)."The Tprk Protein ofTreponema pallidum Is Periplasmic and Is Not a Target of Opsonic Antibody or Protective Immunity".The Journal of Experimental Medicine.193 (9):1015–1026.doi:10.1084/jem.193.9.1015.ISSN 0022-1007.PMC 2193430.PMID 11342586. Archived fromthe original on 4 June 2024.
  41. ^Giacani L, Molini BJ, Kim EY, Godornes BC, Leader BT, Tantalo LC, Centurion-Lara A, Lukehart SA (1 April 2010)."Antigenic variation in Treponema pallidum: TprK sequence diversity accumulates in response to immune pressure during experimental syphilis".Journal of Immunology.184 (7):3822–3829.doi:10.4049/jimmunol.0902788.ISSN 1550-6606.PMC 3042355.PMID 20190145.
  42. ^abTang Y, Zhou Y, He B, Cao T, Zhou X, Ning L, Chen E, Li Y, Xie X, Peng B, Hu Y, Liu S (19 October 2022). "Investigation of the immune escape mechanism ofTreponema pallidum".Infection.51 (2):305–321.doi:10.1007/s15010-022-01939-z.PMID 36260281.S2CID 252994863.
  43. ^Liu D, Tong ML, Lin Y, Liu LL, Lin LR, Yang TC (22 July 2019)."Insights into the genetic variation profile of tprK in Treponema pallidum during the development of natural human syphilis infection".PLOS Neglected Tropical Diseases.13 (7) e0007621.doi:10.1371/journal.pntd.0007621.ISSN 1935-2735.PMC 6675121.PMID 31329597.
  44. ^abcEdmondson DG, Hu B, Norris SJ (June 2018)."Long-Term in Vitro Culture of the Syphilis SpirocheteTreponema pallidum subsp. pallidum".mBio.9 (3) e01153-18.doi:10.1128/mBio.01153-18.PMC 6020297.PMID 29946052.
  45. ^abcEdmondson DG, DeLay BD, Kowis LE, Norris SJ (23 February 2021)."Parameters Affecting Continuous In Vitro Culture ofTreponema pallidum Strains".mBio.12 (1): 10.1128/mbio.03536–20.doi:10.1128/mbio.03536-20.PMC 8545124.PMID 33622721.
  46. ^abEdmondson DG, Norris SJ (February 2021)."In Vitro Cultivation of the Syphilis SpirocheteTreponema pallidum".Current Protocols.1 (2) e44.doi:10.1002/cpz1.44.PMC 7986111.PMID 33599121.
  47. ^Prescott J, Feldmann H, Safronetz D (January 2017)."Amending Koch's postulates for viral disease: When "growth in pure culture" leads to a loss of virulence".Antiviral Research.137:1–5.doi:10.1016/j.antiviral.2016.11.002.PMC 5182102.PMID 27832942.
  48. ^Chen X, Zhao M, Qu H (2015)."Cellular metabolic network analysis: discovering important reactions in Treponema pallidum".BioMed Research International.2015 328568.doi:10.1155/2015/328568.ISSN 2314-6141.PMC 4606156.PMID 26495292.
  49. ^Shahreen N, Chowdhury NB, Stone E, Knobbe E, Saha R (19 November 2024)."Enzyme-constrained Metabolic Model of Treponema pallidum Identified Glycerol-3-phosphate Dehydrogenase as an Alternate Electron Sink".BioRxiv: The Preprint Server for Biology 2024.11.17.624049.doi:10.1101/2024.11.17.624049.ISSN 2692-8205.PMC 11601652.PMID 39605378.
  50. ^Parsonage D, Desrosiers DC, Hazlett KR, Sun Y, Nelson KJ, Cox DL, Radolf JD, Poole LB (19 March 2010)."Broad specificity AhpC-like peroxiredoxin and its thioredoxin reductant in the sparse antioxidant defense system ofTreponema pallidum".Proceedings of the National Academy of Sciences.107 (14):6240–6245.Bibcode:2010PNAS..107.6240P.doi:10.1073/pnas.0910057107.ISSN 0027-8424.PMC 2851974.PMID 20304799.
  51. ^Radolf JD, Desrosiers DC (2009)."Treponema pallidum, the stealth pathogen, changes, but how?".Molecular Microbiology.72 (5):1081–1086.doi:10.1111/j.1365-2958.2009.06711.x.ISSN 1365-2958.PMC 2975512.PMID 19432802.
  52. ^Brautigam CA, Deka RK, Tso SC, Liu WZ, Norgard MV (2023)."Biophysical and biochemical studies support TP0094 as a phosphotransacetylase in an acetogenic energy-conservation pathway in Treponema pallidum".PLOS ONE.18 (5) e0283952.Bibcode:2023PLoSO..1883952B.doi:10.1371/journal.pone.0283952.ISSN 1932-6203.PMC 10194888.PMID 37200262.
  53. ^Deka RK, Tso SC, Liu WZ, Brautigam CA (2025)."Biophysical and biochemical evidence for the role of acetate kinases (AckAs) in an acetogenic pathway in pathogenic spirochetes".PLOS ONE.20 (1) e0312642.Bibcode:2025PLoSO..2012642D.doi:10.1371/journal.pone.0312642.ISSN 1932-6203.PMC 11717252.PMID 39787173.
  54. ^Brautigam CA, Deka RK, Tso SC, Liu WZ, Norgard MV (2023)."Biophysical and biochemical studies support TP0094 as a phosphotransacetylase in an acetogenic energy-conservation pathway in Treponema pallidum".PLOS ONE.18 (5) e0283952.Bibcode:2023PLoSO..1883952B.doi:10.1371/journal.pone.0283952.ISSN 1932-6203.PMC 10194888.PMID 37200262.
  55. ^Chen J, Huang J, Liu Z, Xie Y (27 September 2022)."Treponema pallidum outer membrane proteins: current status and prospects".Pathogens and Disease.80 (1) ftac023.doi:10.1093/femspd/ftac023.ISSN 2049-632X.PMID 35869970.
  56. ^Štaudová B, Strouhal M, Zobaníková M, Čejková D, Fulton LL, Chen L, Giacani L, Centurion-Lara A, Bruisten SM, Sodergren E, Weinstock GM, Šmajs D (6 November 2014)."Whole Genome Sequence of the Treponema pallidum subsp. endemicum Strain Bosnia A: The Genome Is Related to Yaws Treponemes but Contains Few Loci Similar to Syphilis Treponemes".PLOS Neglected Tropical Diseases.8 (11) e3261.doi:10.1371/journal.pntd.0003261.ISSN 1935-2735.PMC 4222731.PMID 25375929.
  57. ^abNoda A, Grillová L, Lienhard R, Blanco O, Rodríguez I, Šmajs D (November 2018)."Bejel in Cuba: molecular identification of Treponema pallidum subsp. endemicum in patients diagnosed with venereal syphilis".Clinical Microbiology and Infection.24 (11): 1210.e1–1210.e5.doi:10.1016/j.cmi.2018.02.006.ISSN 1198-743X.PMID 29454847.
  58. ^Willey JM (2020).Prescott's Microbiology (11th ed.). McGraw-Hill Education. p. 436.ISBN 978-1-260-21188-7.
  59. ^Zobaníková M, Mikolka P, Cejková D, Pospíšilová P, Chen L, Strouhal M, Qin X, Weinstock GM, Smajs D (October 2012)."Complete genome sequence ofTreponema pallidum strain DAL-1".Standards in Genomic Sciences.7 (1):12–21.Bibcode:2012SGenS...7...12Z.doi:10.4056/sigs.2615838.PMC 3570794.PMID 23449808.
  60. ^Tong ML, Zhao Q, Liu LL, Zhu XZ, Gao K, Zhang HL, Lin LR, Niu JJ, Ji ZL, Yang TC (2017)."Whole genome sequence of theTreponema pallidum subsp. pallidum strain Amoy: An Asian isolate highly similar to SS14".PLOS ONE.12 (8) e0182768.Bibcode:2017PLoSO..1282768T.doi:10.1371/journal.pone.0182768.PMC 5546693.PMID 28787460.
  61. ^abcPla-Díaz M, Sánchez-Busó L, Giacani L, Šmajs D, Bosshard PP, Bagheri HC, Schuenemann VJ, Nieselt K, Arora N, González-Candelas F (7 January 2022). Crandall K (ed.)."Evolutionary Processes in the Emergence and Recent Spread of the Syphilis Agent, Treponema pallidum".Molecular Biology and Evolution.39 (1) msab318.doi:10.1093/molbev/msab318.ISSN 0737-4038.PMC 8789261.PMID 34791386.
  62. ^abArora N, Schuenemann VJ, Jäger G, Peltzer A, Seitz A, Herbig A, Strouhal M, Grillová L, Sánchez-Busó L, Kühnert D, Bos KI, Davis LR, Mikalová L, Bruisten S, Komericki P (5 December 2016)."Origin of modern syphilis and emergence of a pandemic Treponema pallidum cluster".Nature Microbiology.2 (1): 16245.doi:10.1038/nmicrobiol.2016.245.hdl:10550/58402.ISSN 2058-5276.PMID 27918528.
  63. ^Papp JR (2024)."CDC Laboratory Recommendations for Syphilis Testing, United States, 2024".MMWR. Recommendations and Reports.73 (1):1–32.doi:10.15585/mmwr.rr7301a1.ISSN 1057-5987.PMC 10849099.PMID 38319847.
  64. ^Gall GE, Lautenschlager S, Bagheri HC (6 June 2016)."Quarantine as a public health measure against an emerging infectious disease: syphilis in Zurich at the dawn of the modern era (1496–1585)".GMS Hygiene and Infection Control; 11:Doc13.11: Doc13.doi:10.3205/DGKH000273.ISSN 2196-5226.PMC 4899769.PMID 27303653.
  65. ^"Syphilis".www.pennmedicine.org. 10 September 2022. Retrieved11 September 2024.
  66. ^Hu YT, Wu KX, Wang XT, Zhao YY, Jiang XY, Liu D, Tong ML, Liu LL (23 August 2023). Blanke SR (ed.)."Treponema pallidum promoted microglia apoptosis and prevented itself from clearing by human microglia via blocking autophagic flux".PLOS Pathogens.19 (8) e1011594.doi:10.1371/journal.ppat.1011594.ISSN 1553-7374.PMC 10446187.PMID 37611054.
  67. ^Dofitas BL, Kalim SP, Toledo CB, Richardus JH (30 January 2020)."Yaws in the Philippines: first reported cases since the 1970s".Infectious Diseases of Poverty.9 (1) 1.doi:10.1186/s40249-019-0617-6.ISSN 2095-5162.PMC 6990502.PMID 31996251.
  68. ^abMitjà O, Marks M, Konan DJ, Ayelo G, Gonzalez-Beiras C, Boua B, Houinei W, Kobara Y, Tabah EN, Nsiire A, Obvala D, Taleo F, Djupuri R, Zaixing Z, Utzinger J (1 June 2015)."Global epidemiology of yaws: a systematic review".The Lancet Global Health.3 (6):e324 –e331.doi:10.1016/S2214-109X(15)00011-X.ISSN 2214-109X.PMC 4696519.PMID 26001576.
  69. ^"Yaws (Endemic treponematoses)".www.who.int. Retrieved20 November 2024.
  70. ^Wicher K, Wicher V, Abbruscato F, Baughn RE (June 2000). Barbieri JT (ed.)."Treponema pallidum subsp. pertenue Displays Pathogenic Properties Different from Those of T. pallidum subsp. pallidum".Infection and Immunity.68 (6):3219–3225.doi:10.1128/IAI.68.6.3219-3225.2000.ISSN 0019-9567.PMC 97566.PMID 10816466.
  71. ^Marks M, Lebari D, Solomon AW, Higgins SP (26 September 2015)."Yaws".International Journal of STD & AIDS.26 (10):696–703.doi:10.1177/0956462414549036.ISSN 1758-1052.PMC 4655361.PMID 25193248.
  72. ^Marks M (September 2018)."Advances in the Treatment of Yaws".Tropical Medicine and Infectious Disease.3 (3): 92.doi:10.3390/tropicalmed3030092.ISSN 2414-6366.PMC 6161241.PMID 30274488.
  73. ^Marks M, Mitjà O, Solomon AW, Asiedu KB, Mabey DC (2015)."Yaws".British Medical Bulletin.113 (1):91–100.doi:10.1093/bmb/ldu037.ISSN 1471-8391.PMC 4350436.PMID 25525120.
  74. ^Mitjà O, Hays R, Ipai A, Penias M, Paru R, Fagaho D, de Lazzari E, Bassat Q (28 January 2012). "Single-dose azithromycin versus benzathine benzylpenicillin for treatment of yaws in children in Papua New Guinea: an open-label, non-inferiority, randomised trial".Lancet.379 (9813):342–347.doi:10.1016/S0140-6736(11)61624-3.ISSN 1474-547X.PMID 22240407.
  75. ^Štaudová B, Strouhal M, Zobaníková M, Čejková D, Fulton LL, Chen L, Giacani L, Centurion-Lara A, Bruisten SM, Sodergren E, Weinstock GM, Šmajs D (6 November 2014)."Whole Genome Sequence of the Treponema pallidum subsp. endemicum Strain Bosnia A: The Genome Is Related to Yaws Treponemes but Contains Few Loci Similar to Syphilis Treponemes".PLOS Neglected Tropical Diseases.8 (11) e3261.doi:10.1371/journal.pntd.0003261.ISSN 1935-2735.PMC 4222731.PMID 25375929.
  76. ^"Penicillin g benzathine (intramuscular route)".Mayo Clinic. Retrieved6 November 2024.
  77. ^abChuma IS, Batamuzi EK, Collins DA, Fyumagwa RD, Hallmaier-Wacker LK, Kazwala RR, Keyyu JD, Lejora IA, Lipende IF, Lüert S, Paciência FM, Piel A, Stewart FA, Zinner D, Roos C (June 2018)."Widespread Treponema pallidum Infection in Nonhuman Primates, Tanzania".Emerging Infectious Diseases.24 (6):1002–1009.doi:10.3201/eid2406.180037.ISSN 1080-6040.PMC 6004850.PMID 29774840.
  78. ^abFantry LE, Tramont EC."Treponema Pallidum (Syphilis)".Infectious Disease and Antimicrobial Agents. Retrieved12 November 2019 – via www.antimicrobe.org.
  79. ^abcStamm LV (1 February 2010)."Global Challenge of Antibiotic-ResistantTreponema pallidum".Antimicrobial Agents and Chemotherapy.54 (2):583–9.doi:10.1128/AAC.01095-09.PMC 2812177.PMID 19805553.
  80. ^Updated recommendations for the treatment of Neisseria gonorrhoeae, Chlamydia trachomatis, and Treponema pallidum (syphilis) and new recommendations on syphilis testing and partner services. World Health Organization. 17 July 2024.doi:10.2471/b09100.
  81. ^Lithgow KV, Cameron CE (18 July 2016)."Vaccine development for syphilis".Expert Review of Vaccines.16 (1):37–44.doi:10.1080/14760584.2016.1203262.ISSN 1744-8395.PMC 5513191.PMID 27328030.
  82. ^Ávila-Nieto C, Pedreño-López N, Mitjà O, Clotet B, Blanco J, Carrillo J (6 April 2023)."Syphilis vaccine: challenges, controversies and opportunities".Frontiers in Immunology.14 1126170.doi:10.3389/fimmu.2023.1126170.ISSN 1664-3224.PMC 10118025.PMID 37090699.
  83. ^Liu D, Chen R, Wang YJ, Li W, Liu LL, Lin LR, Yang TC, Tong ML (29 September 2023)."Insights into the protective immune response by immunization with full-length recombinant TprK protein: cellular and humoral responses".npj Vaccines.8 (1): 146.doi:10.1038/s41541-023-00748-1.ISSN 2059-0105.PMC 10542339.PMID 37773233.
  84. ^Tomson FL, Conley PG, Norgard MV, Hagman KE (September 2007)."Assessment of cell-surface exposure and vaccinogenic potentials ofTreponema pallidum candidate outer membrane proteins".Microbes and Infection.9 (11):1267–75.doi:10.1016/j.micinf.2007.05.018.PMC 2112743.PMID 17890130.
  85. ^Cameron CE, Lukehart SA (March 2014)."Current status of syphilis vaccine development: need, challenges, prospects".Vaccine.32 (14):1602–9.doi:10.1016/j.vaccine.2013.09.053.PMC 3951677.PMID 24135571.
  86. ^Radolf JD, Kumar S (2018). "The Treponema pallidum Outer Membrane".Spirochete Biology: The Post Genomic Era. Current Topics in Microbiology and Immunology. Vol. 415. pp. 1–38.doi:10.1007/82_2017_44.ISBN 978-3-319-89637-3.ISSN 0070-217X.PMC 5924592.PMID 28849315.
  87. ^Ávila-Nieto C, Pedreño-López N, Mitjà O, Clotet B, Blanco J, Carrillo J (2023)."Syphilis vaccine: challenges, controversies and opportunities".Frontiers in Immunology.14 1126170.doi:10.3389/fimmu.2023.1126170.ISSN 1664-3224.PMC 10118025.PMID 37090699.

Further reading

[edit]

External links

[edit]
Spirochaetota
Spirochaetaceae
Treponema
Borrelia
Leptospiraceae
Leptospira
Chlamydiota
Chlamydia
Bacteroidota
Fusobacteriota
Treponema pallidum
National
Other
Retrieved from "https://en.wikipedia.org/w/index.php?title=Treponema_pallidum&oldid=1324482973"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp